Laigo Bio: Valuation, Funding & Investors
Yalelaan 62 Life Sciences Incubator Rm 2.05 Utrecht Science Park Utrecht, 3584 CM, NLhttps://www.laigobio.com/Therapeutics
An early stage biotech company based in the Netherlands, pioneering novel therapies using its proprietary SureTAC™ precision membrane protein degradation platform. The company focuses on selective degradation of membrane-bound targets involved in autoimmune and inflammatory diseases.
Leadership & Board
- Current Number of Employees
- 22
- Current LinkedIn Followers
- 2,216
Latest Estimated Valuation
- Total Amount Raised
- $12M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $12M
- Latest Funding Round
- Seed Round
Employee Trend
Laigo Bio had 22 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
22Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Laigo Bio had 2,216 followers as of October 26, 2026. The number of followers increased by 21 (0.96%) week-over-week.
2,216Latest Followers Count
21(0.96%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 04, 2025 | Seed Round | $11.50M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Kurma Partners | Seed Round |
| Angelini Ventures | Seed Round |
| Eurazeo | Seed Round |
| Cancer Research Horizons | Seed Round |
| Curie Capital | Seed Round |
| Argobio Studio | Seed Round |
| Oncode Bridge Fund | Seed Round |
| ROM Utrecht region | Seed Round |
Similar Companies
A snapshot of private companies similar to Laigo Bio, helping you discover and navigate related company profiles.
